Antidepressant Sales Surge in Russia Amidst War and Economic Strain

• Antidepressant sales in Russia have surged to unprecedented levels, nearly tripling pre-pandemic volumes, reflecting prolonged psychological strain from the Russo-Ukrainian War and economic hardship.
• Market research shows a steep upward trajectory, with 22.3 million packages sold by last year, and a 36% expansion in 2025, pushing antidepressants into the top tier of Russia's retail pharmaceutical market.
• The increase is linked to reduced mental health stigma, economic and social shocks, intensified political repression, and the psychological toll of living under sustained repression and war.
• Economic pressures, including worsening national economy perceptions, difficulties affording food, and rising food prices (e.g., potatoes up 167%), contribute to widespread anxiety.
• Despite state narratives, many widely used antidepressants are Western-developed, and the country faces recurring supply problems and pharmacy closures, making consistent access precarious.